Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection-Reference-Cited by-同舟云学术

Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

Published:2013-01 Issue:1 Volume:11 Page:81-87.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Flamm Steven L.,Lawitz Eric,Jacobson Ira,Bourlière Marc,Hezode Christophe,Vierling John M.,Bacon Bruce R.,Niederau Claus,Sherman Morris,Goteti Venkata,Sings Heather L.,Barnard Richard O.,Howe John A.,Pedicone Lisa D.,Burroughs Margaret H.,Brass Clifford A.,Albrecht Janice K.,Poordad Fred

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference14 articles.

1. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?;Zeuzem;Ann Intern Med,2004

2. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009

3. Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy;Parise;Braz J Infect Dis,2006

4. Weight-based combination therapy with peginterferon alpha-2b and ribavirin for naive, relapser and non-responder patients with chronic hepatitis C;Goncales;Braz J Infect Dis,2006

5. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy;Poynard;Gastroenterology,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

2. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective;Value in Health Regional Issues;2019-12

3. Safety, Tolerability, and Associated Side Effects of Direct- Acting Antivirals;Hepatitis C - From Infection to Cure;2018-10-10

4. Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era;Immunological Reviews;2018-08-11

5. Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan;Journal of the Formosan Medical Association;2018-06